Search Results

Filter
  • 1-10 of  19,695 results for ""Pituitary Adenylate Cyclase-Activating Polypeptide""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Immunostimulant effects of Pituitary Adenylate Cyclase-Activating Polypeptide and double-stranded (ds)RNA in Orconectes propinquus.

  • Authors : Monod EC; Department of Biology, Wilfrid Laurier University, Waterloo, Canada; Department of Biology, University of Waterloo, Waterloo, Canada.

Subjects: Pituitary Adenylate Cyclase-Activating Polypeptide*/Pituitary Adenylate Cyclase-Activating Polypeptide*/Pituitary Adenylate Cyclase-Activating Polypeptide*/pharmacology ; Adjuvants, Immunologic*/Adjuvants, Immunologic*/Adjuvants, Immunologic*/pharmacology; Animals

  • Source: Fish & shellfish immunology [Fish Shellfish Immunol] 2024 Mar; Vol. 146, pp. 109388. Date of Electronic Publication: 2024 Jan 18.Publisher: Academic Press Country of Publication: England NLM ID: 9505220 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Protective effect of pituitary adenylate cyclase activating polypeptide in diabetic keratopathy.

  • Authors : Maugeri G; Section of Anatomy, Histology and Movement Sciences, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.; D'Amico AG

Subjects: Diabetes Mellitus, Experimental*/Diabetes Mellitus, Experimental*/Diabetes Mellitus, Experimental*/drug therapy ; Pituitary Adenylate Cyclase-Activating Polypeptide*/Pituitary Adenylate Cyclase-Activating Polypeptide*/Pituitary Adenylate Cyclase-Activating Polypeptide*/metabolism; Animals

  • Source: Peptides [Peptides] 2023 Dec; Vol. 170, pp. 171107. Date of Electronic Publication: 2023 Sep 28.Publisher: Elsevier Science Inc Country of Publication: United States NLM ID: 8008690 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Impact Assessment of Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) and Hemostatic Sponge on Vascular Anastomosis Regeneration in Rats.

  • Authors : Fazekas LA; Department of Operative Techniques and Surgical Research, Faculty of Medicine, University of Debrecen, Moricz Zsigmond ut 22, H-4032 Debrecen, Hungary.; Szabo B

Subjects: Pituitary Adenylate Cyclase-Activating Polypeptide*/Pituitary Adenylate Cyclase-Activating Polypeptide*/Pituitary Adenylate Cyclase-Activating Polypeptide*/pharmacology ; Hemostatics*/Hemostatics*/Hemostatics*/pharmacology; Rats

  • Source: International journal of molecular sciences [Int J Mol Sci] 2023 Nov 24; Vol. 24 (23). Date of Electronic Publication: 2023 Nov 24.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Dynamic, sex- and diet-specific pleiotropism in the PAC1 receptor-mediated regulation of arcuate proopiomelanocortin and Neuropeptide Y/Agouti related peptide neuronal excitability by anorexigenic ventromedial nucleus PACAP neurons.

  • Authors : Mata-Pacheco V; Graduate College of Biomedical Sciences, Western University of Health Sciences, Pomona, California, USA.; Hernandez J

Subjects: Pro-Opiomelanocortin*/Pro-Opiomelanocortin*/Pro-Opiomelanocortin*/metabolism ; Pituitary Adenylate Cyclase-Activating Polypeptide*/Pituitary Adenylate Cyclase-Activating Polypeptide*/Pituitary Adenylate Cyclase-Activating Polypeptide*/metabolism; Animals

  • Source: Journal of neuroendocrinology [J Neuroendocrinol] 2024 Jan; Vol. 36 (1), pp. e13357. Date of Electronic Publication: 2023 Dec 06.Publisher: Wiley & Sons Country of Publication: United States NLM ID: 8913461 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention.

  • Authors : Pellesi L; Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.; Ashina M

Subjects: Pituitary Adenylate Cyclase-Activating Polypeptide*/Pituitary Adenylate Cyclase-Activating Polypeptide*/Pituitary Adenylate Cyclase-Activating Polypeptide*/pharmacology ; Pituitary Adenylate Cyclase-Activating Polypeptide*/Pituitary Adenylate Cyclase-Activating Polypeptide*/Pituitary Adenylate Cyclase-Activating Polypeptide*/metabolism ; Migraine Disorders*/Migraine Disorders*/Migraine Disorders*/drug therapy

  • Source: Expert opinion on emerging drugs [Expert Opin Emerg Drugs] 2024 Mar; Vol. 29 (1), pp. 57-64. Date of Electronic Publication: 2024 Feb 12.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101135662 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Long-term Effects of the pituitary-adenylate cyclase-activating Polypeptide (PACAP38) in the Adult Mouse Retina: Microglial Activation and Induction of Neural Proliferation.

  • Authors : Denes V; Department of Neurobiology, University of Pécs, 6 Ifjúság str, Pécs, H-7624, Hungary. .; Lukats A

Subjects: Pituitary Adenylate Cyclase-Activating Polypeptide*/Pituitary Adenylate Cyclase-Activating Polypeptide*/Pituitary Adenylate Cyclase-Activating Polypeptide*/pharmacology ; Microglia*; Mice

  • Source: Neurochemical research [Neurochem Res] 2023 Nov; Vol. 48 (11), pp. 3430-3446. Date of Electronic Publication: 2023 Jul 19.Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 7613461 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Hippocampal pituitary adenylate cyclase-activating polypeptide mediates rapid antidepressant-like effects of Yueju pill.

  • Authors : Ren L; School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611130, China. Electronic address: .; Zhang H

Subjects: Pituitary Adenylate Cyclase-Activating Polypeptide*/Pituitary Adenylate Cyclase-Activating Polypeptide*/Pituitary Adenylate Cyclase-Activating Polypeptide*/metabolism ; Drugs, Chinese Herbal*/Drugs, Chinese Herbal*/Drugs, Chinese Herbal*/pharmacology; Mice

  • Source: Neuropeptides [Neuropeptides] 2023 Oct; Vol. 101, pp. 102350. Date of Electronic Publication: 2023 Jun 01.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8103156 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Discovery and In Vitro Characterization of BAY 2686013, an Allosteric Small Molecule Antagonist of the Human Pituitary Adenylate Cyclase-Activating Polypeptide Receptor.

  • Authors : Langer G; Bayer AG, Research & Development, Pharmaceuticals, Berlin, Germany (G.L., U.B., J.M., B.l.R., S.B.); Bayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany (C.O., A.L.-B.)

Subjects: Pituitary Adenylate Cyclase-Activating Polypeptide*/Pituitary Adenylate Cyclase-Activating Polypeptide*/Pituitary Adenylate Cyclase-Activating Polypeptide*/pharmacology ; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I*/Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I*/Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I*/chemistry; Humans

  • Source: Molecular pharmacology [Mol Pharmacol] 2023 Sep; Vol. 104 (3), pp. 105-114. Date of Electronic Publication: 2023 Jun 22.Publisher: American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States NLM ID: 0035623 Publication Model:

Record details

×
  • 1-10 of  19,695 results for ""Pituitary Adenylate Cyclase-Activating Polypeptide""